Currax Pharmaceuticals, a US biopharmaceutical company, filed a complaint alleging that Found Health is falsely marketing medications to patients as the generic equivalent of CONTRAVE® when no generic equivalent exists. The complaint details numerous federal and state claims including trademark infringement, false advertising, unfair competition, and false designation of origin.
|
CONTRAVE® is FDA approved and indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30kg/m2 or greater (obese), or adults with a BMI of 27kg/m2 or greater (overweight) with at least one weight-related medical problem such as high blood pressure, high cholesterol, or type 2 Diabetes, to lose weight and maintain weight loss. Four phase III clinical trials were performed to establish and validate the weight loss indication.
|